The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database

Background: The safety of prescribing angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) during acute kidney injury (AKI) remains unclear. We aimed to investigate the associations of ACEI/ARB therapy in AKI with the risk of mortality, acute kidney disease (AKD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xu, Xue, Jing, Liu, Zheng, Dai, Wenjie, Xiang, Jingsha, Xu, Hui, Zhou, Qiaoling, Zhou, Quan, Wei, Xinran, Chen, Wenhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465288/
https://www.ncbi.nlm.nih.gov/pubmed/36105224
http://dx.doi.org/10.3389/fphar.2022.918385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465288/
https://www.ncbi.nlm.nih.gov/pubmed/36105224
http://dx.doi.org/10.3389/fphar.2022.918385

Ejemplares similares